Laporan Laba Rugi (TTM)
Laporan Laba Rugi Lexaria Bioscience Corp. - Equity Warrant menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 11-30 |
2021 02-28 |
2021 05-31 |
2021 08-31 |
2021 11-30 |
2022 02-28 |
2022 05-31 |
2022 08-31 |
2022 11-30 |
2023 02-28 |
2023 05-31 |
2023 08-31 |
2023 11-30 |
2024 02-29 |
2024 05-31 |
2024 08-31 |
2024 11-30 |
2025 02-28 |
2025 05-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Change (%) | 17.11 | 7.52 | -4.36 | -38.99 | -36.59 | -37.32 | 45.72 | 32.83 | -3.13 | -2.00 | -29.76 | 23.67 | 44.67 | 1.55 | 12.96 | 7.03 | 5.84 | 17.11 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change (%) | -17.65 | 24.47 | 9.66 | -33.60 | -20.77 | -44.83 | 41.14 | 14.23 | -4.18 | -7.49 | -56.70 | -34.83 | -14.41 | -72.55 | 0.00 | -43.59 | 0.00 | 0.00 | |
| % of Revenue | 26.00 | 18.28 | 21.16 | 24.26 | 26.41 | 32.99 | 29.04 | 28.13 | 24.19 | 23.93 | 22.59 | 13.93 | 7.34 | 4.34 | 1.17 | 1.04 | 0.55 | 0.52 | 0.44 |
| Gross Operating Profit | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Change (%) | 29.33 | 3.73 | -8.13 | -40.71 | -42.27 | -33.62 | 47.59 | 40.11 | -2.80 | -0.27 | -21.90 | 33.13 | 49.35 | 4.92 | 13.11 | 7.56 | 5.87 | 17.20 | |
| % of Revenue | 74.00 | 81.72 | 78.84 | 75.74 | 73.59 | 67.01 | 70.96 | 71.87 | 75.81 | 76.07 | 77.41 | 86.07 | 92.66 | 95.66 | 98.83 | 98.96 | 99.45 | 99.48 | 99.56 |
| SG&A | 4 | 4 | 5 | 5 | 6 | 6 | 5 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 5 | 5 |
| Change (%) | 6.73 | 21.02 | -2.44 | 16.11 | 1.87 | -8.65 | -7.66 | -12.20 | -12.69 | -24.30 | 2.69 | -8.01 | -2.84 | 14.04 | 25.97 | 5.47 | 16.79 | -0.48 | |
| % of Revenue | 657.31 | 599.05 | 674.26 | 687.85 | 1,309.05 | 2,102.99 | 3,064.59 | 1,942.04 | 1,283.62 | 1,156.93 | 893.61 | 1,306.43 | 971.75 | 652.59 | 732.82 | 817.22 | 805.31 | 888.65 | 755.13 |
| R&D | 0 | 0 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 4 | 4 | 3 | 3 | 2 | 2 | 4 | 5 | 7 |
| Change (%) | -2.15 | 93.11 | 41.64 | 21.10 | 6.49 | 18.28 | -4.34 | 20.12 | 19.00 | 33.73 | 4.09 | -6.95 | -13.20 | -36.05 | 24.65 | 58.41 | 38.51 | 41.40 | |
| % of Revenue | 78.63 | 65.69 | 117.98 | 174.74 | 346.82 | 582.47 | 1,099.05 | 721.49 | 652.45 | 801.50 | 1,093.74 | 1,620.95 | 1,219.56 | 731.69 | 460.75 | 508.44 | 752.49 | 984.83 | 1,189.08 |
| OpEx | 5 | 5 | 6 | 6 | 7 | 8 | 7 | 7 | 7 | 7 | 6 | 7 | 6 | 6 | 5 | 6 | 8 | 10 | 12 |
| Change (%) | 4.39 | 27.79 | 5.72 | 15.74 | 2.46 | -3.32 | -6.45 | -3.26 | -2.04 | -0.63 | 2.78 | -7.56 | -8.63 | -12.62 | 25.43 | 25.72 | 27.27 | 21.53 | |
| % of Revenue | 757.36 | 675.09 | 802.31 | 886.85 | 1,682.27 | 2,718.46 | 4,192.68 | 2,691.67 | 1,960.26 | 1,982.36 | 2,009.94 | 2,941.31 | 2,198.65 | 1,388.62 | 1,194.74 | 1,326.70 | 1,558.35 | 1,874.00 | 1,944.66 |
| Operating Income | -4 | -4 | -5 | -6 | -7 | -7 | -7 | -7 | -6 | -6 | -6 | -6 | -6 | -5 | -4 | -6 | -7 | -9 | -11 |
| Change (%) | 2.46 | 31.31 | 7.15 | 22.69 | 4.93 | -2.02 | -7.72 | -4.65 | -1.98 | -0.56 | 4.49 | -8.65 | -11.17 | -13.72 | 26.57 | 27.24 | 28.74 | 21.78 | |
| % of Revenue | -657.36 | -575.09 | -702.31 | -786.85 | -1,582.27 | -2,618.46 | -4,092.68 | -2,591.67 | -1,860.26 | -1,882.36 | -1,909.94 | -2,841.31 | -2,098.65 | -1,288.62 | -1,094.74 | -1,226.70 | -1,458.35 | -1,774.00 | -1,844.66 |
| Interest Expense | |||||||||||||||||||
| Change (%) | |||||||||||||||||||
| % of Revenue | |||||||||||||||||||
| Net Income | -4 | -2 | -4 | -4 | -5 | -7 | -7 | -7 | -7 | -7 | -7 | -7 | -6 | -5 | -5 | -6 | -7 | -9 | -11 |
| Change (%) | -36.38 | 55.16 | 9.59 | 32.21 | 34.37 | -2.43 | 4.15 | -3.26 | -1.82 | -0.17 | -3.31 | -8.65 | -10.65 | -10.84 | 19.49 | 26.30 | 28.19 | 21.39 | |
| % of Revenue | -620.33 | -336.96 | -486.24 | -557.19 | -1,207.39 | -2,558.61 | -3,982.44 | -2,846.28 | -2,072.83 | -2,101.00 | -2,140.30 | -2,946.36 | -2,176.32 | -1,344.04 | -1,179.96 | -1,248.25 | -1,473.01 | -1,784.18 | -1,849.39 |
Source: Capital IQ
